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Summary 
Background: The trace metal ions Zn2+ and Cu2+ are increasingly recognized as endogenous 
modulators of neuronal transmission, hormone secretion and synaptic plasticity. Cav2.3-type 
voltage-gated Ca2+ channels (VGCCs) are among their most sensitive targets and have an 
expression pattern that coincides with the spatial distribution of histochemically reactive trace 
metals in the brain, suggesting that they could represent a main mediator for their reported 
neuro-modulatory effects. Although non-conserved histidine residues on the external side of 
domain I have been convincingly implicated in the effects of trace metals on Cav2.3 channel 
gating, the exact mechanisms involved and their (patho)physiological relevance remain 
incompletely understood. 
Aims: Aim of the articles compiled in the present thesis was to shed some light on the exact 
mechanisms of Zn2+- and Cu2+-induced Cav2.3 channel modulation and their potential relevance 
under normal and pathophysiological conditions. 
Methods: In publication 1, crystallographic data of a Ca2+-selective bacterial model channel was 
used as a framework to theoretically analyze eukaryotic VGCC structure, function and 
modulation by inorganic cations. In publication 2, general protocols for preparation and use of 
metal ion-buffered solutions were developed and a fluorescent Zn2+ sensor was used to illustrate 
the importance of proper metal ion-buffering. In publication 3, conventional and perforated 
patch-clamp recordings together with different inhibitors and cytosolic factors were used to 
study Cav2.3 channel run-down during electrophysiological recordings, which was critical to 
optimize the conditions for experiments performed in publication 6. In publication 4, the effects 
of intraperitoneal injection of the Zn2+ chelator DEDTC on blood glucose homeostasis, glucose 
tolerance and peptide hormone secretion in Cav2.3-deficient and -competent mice were analyzed, 
insulin secretion was examined in isolated islets of Langerhans from both genotypes and the 
Zn2+-dependence of DEDTC effects on cloned Cav2.3 channels was verified using whole-cell 
patch-clamp recordings. In publication 5, whole-cell patch-clamp and electroretinographic 
recordings were used to characterize a receptor-independent but Cu2+-dependent mechanism of 
Cav2.3 channel modulation by the glutamate-receptor agonist kainic acid (KA). In publication 6, 
whole-cell patch-clamp recordings were used to characterize Zn2+-induced changes in Cav2.3 
channel function and to develop a Markov model for Cav2.3 channel gating under control 
conditions and in the presence of physiological Zn2+ concentrations. 
Results: Publication 1 provided novel insights into eukaryotic VGCC function and modulation 
by trace metal ions. Publication 2 demonstrated the critical importance of proper metal ion 
buffering to avoid deviations between nominal and actual free metal ion concentrations. 
Publication 3 showed that run-down of Cav2.3 channel currents is associated with changes in 
channel gating and that it can be prevented or delayed by hydrolysable ATP through a 
mechanism that critically depends on protein phosphorylation by serine/threonine kinases. 
Publication 4 revealed severe glucose intolerance in Zn2+-depleted Cav2.3-deficient but not 
vehicle-treated Cav2.3-deficient or Zn2+-depleted wildtype mice. In addition, fasting glucose and 
glucagon levels were significantly higher in Cav2.3-deficient mice, whereas Zn2+ chelation 
significantly increased blood glucose and glucagon concentrations in wildtype but not Cav2.3-
deficient mice. Application of DEDTC significantly stimulated cloned human Cav2.3 channels 
when applied in the presence of Zn2+ but had no effect in the presence of the Zn2+ chelator 
CaEDTA. Publication 5 uncovered that KA can stimulate cloned human Cav2.3 channels in the 
absence of functional KA receptors by reversing Cu2+-induced suppression in vitro, presumably 
via formation of stable kainate-Cu2+ complexes. When the chelator tricine was used as a surrogate 
to study the receptor-independent effects of KA in the isolated bovine retina, it selectively 
reduced a late ERG b-wave component that was previously shown to be enhanced by 
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pharmacologic or genetic ablation of Cav2.3 channels. Publication 6 demonstrated that Zn2+-
induced changes in Cav2.3 channel function are complex and inconsistent with a single 
mechanisms of action. Computer simulations were used to show that most, but not all of the 
effects can be reconciled by a simplified Markov model that involves Zn2+ binding to a first site 
with an associated electrostatic modification and mechanical slowing of one of the voltage-
sensors and Zn2+-binding to a second, lower affinity site which blocks the channel and modifies 
the opening and closing transitions.  
Discussion: With regard to Zn2+-induced Cav2.3 channel modulation, the results in publication 6 
point to an intricate dependence on the prevailing neuronal properties and ionic conditions, 
which could profoundly influence and even invert the net Zn2+ action. Thus, due to Zn2+-induced 
parallel changes in activation and inactivation voltage-dependence, the net action is strongly 
affected by the holding potential, can be either inhibitory or stimulatory and may persist for 
several minutes after cessation of the Zn2+ signal. This could conceivably play a role for certain 
forms of synaptic sensitization or plasticity, and might also be relevant for e.g. the regulation of 
Cav2.3 channels in pancreatic islets, where sudden cessation of Zn2+ supply from β-cells is 
thought to serve as one of the switch-off signals for α-cell glucagon secretion. In support of the 
latter notion, the findings in publication 4 provide evidence for an involvement of Cav2.3 
channels in the Zn2+-mediated suppression of glucagon secretion during hyperglycemia and 
indicate that Cav2.3 channel dysfunction could lead to severe disturbances in glucose 
homeostasis, especially under conditions of Zn2+-deficiency. Based on the results of publications 5 
and 6, a decrease or reversal of Zn2+ and Cu2+-induced Cav2.3 channel suppression by 
endogenous (i.e. glutamate) or exogenous (i.e. KA) trace metal chelators, moderate acidification 
or depolarization of the neuronal resting membrane potential could also contribute to the pro-
convulsive role of Cav2.3 channels demonstrated in previous investigations, although the 
pathophysiological relevance of these finding in vivo remains to be firmly established. Finally, the 
findings in publication 3 suggest that protein phosphorylation is required for normal Cav2.3 
channel function and that it could modify the normal properties of currents carried by these 
channels.  
Conclusion: The articles compiled in this thesis provide several novel insights into the 
mechanisms underlying reciprocal Cav2.3 channel modulation by trace metal ions and trace metal 
chelators as well as first evidence for their importance under (patho)physiological conditions. 
Moreover, while still far from complete, the model developed in publication 6 provides a 
quantitative framework for understanding Zn2+ effects on Cav2.3 channel function and a first step 
towards the application of computational approaches for predicting the complex action of Zn2+ on 
neuronal excitability. 
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Zusammenfassung 
Hintergrund: Die Spurenmetallkationen Zn2+ und Cu2+ werden zunehmend als endogene 
Botenstoffe erkannt, welche in die Regulierung von neuronaler Erregbarkeit, Hormonfreisetzung 
und synaptischer Plastizität involviert sind. Cav2.3 spannungsgesteuerte Ca2+ Kanäle gehören zu 
deren sensibelsten Targets und weisen ein Expressionsmuster auf, das mit der Verteilung von 
histochemisch reaktiven Spurenmetallkationen im Gehirn übereinstimmt, so dass sie einen 
Hauptmediator für deren neuro-modulatorischen Effekte darstellen könnten. Obwohl nicht-
konservierte Histidinreste auf der extrazellulären Seite von Domäne I nachweislich eine Rolle für 
Spurenmetall-induzierte Veränderungen im Schaltverhalten von Cav2.3 Kanälen spielen, sind 
viele Fragen bezüglich der zugrundeliegenden Mechanismen und ihrer (patho)physiologischen 
Relevanz bisher unbeantwortet.     
Ziele: Ziel der in dieser Arbeit zusammengestellten Artikel war es, einen besseren Einblick in die 
exakten Mechanismen der Zn2+- und Cu2+-vermittelten Modulation von Cav2.3 Kanälen sowie 
deren potentieller Bedeutung unter normalen und pathophysiologischen Bedingungen zu 
erhalten.  
Methoden: In Publikation 1 wurden auf Basis kristallographischer Daten eines Ca2+-selektiven 
bakteriellen Modellkanals die Struktur, Funktion und Modulation von eukaryotischen Ca2+ 
Kanälen theoretisch analysiert. In Publikation 2 wurden generelle Protokolle für die Herstellung 
und Verwendung von Spurenmetallionen-gepufferten physiologischen Lösungen erarbeitet und 
deren praktische Bedeutung mit einem fluoreszenten Zn2+ Indikator untersucht. In Publikation 3 
wurden konventionelle und perforierte Ganzzell Patch-clamp Messungen sowie verschiedene 
Inhibitoren und zytosolische Faktoren verwendet um den Run-down von Cav2.3 Kanälen 
während elektrophysiologischer Messungen zu untersuchen und die Messbedingungen für die 
Versuche in Publikation 6 zu optimieren. In Publikation 4 wurde untersucht, wie intraperitoneale 
Injektionen des Komplexbildners DEDTC die Blutglukose-Homöostase, Glukosetoleranz und 
Peptidhormonfreisetzung in Cav2.3-defizienten und -kompetenten Mäusen beeinflussen. 
Außerdem wurde die Insulinfreisetzung in isolierten Langerhans Inseln beider Genotypen 
verglichen sowie die Zn2+-Abhängigkeit der Effekte von DEDTC auf rekombinante Cav2.3 Kanäle 
in Ganzzell Patch-Clamp Messungen verifiziert. In Publikation 5 wurden Ganzzell Patch-clamp 
Messungen und elektroretinographische Ableitungen zur Charakterisierung eines Rezeptor-
unabhängigen, Cu2+-abhängigen Mechanismus der Cav2.3 Kanal Modulation durch den 
Glutamatrezeptor Agonisten Kainsäure (KA) untersucht. In Publikation 6 wurden die 
elektrophysiologischen Effekte von Zn2+ auf rekombinante Cav2.3 Kanäle untersucht und ein 
Markov Model für deren Schaltverhalten unter Kontrollbedingungen sowie in Gegenwart 
physiologisch relevanter Zn2+ Konzentrationen entwickelt.  
Ergebnisse: Publikation 1 erbrachte neue Erkenntnisse zur Funktion eukaryotischer 
spannungsgesteuerter Ca2+ Kanäle und deren Modulation durch Spurenmetallkationen. 
Publikation 2 veranschaulichte die Wichtigkeit von Metallionen-Puffern zur Vermeidung von 
Abweichungen zwischen der nominellen und tatsächlichen freien Metallionenkonzentration in 
physiologischen Lösungen. Publikation 3 ergab, dass der Run-down von Cav2.3 Kanälen mit 
Veränderungen im Schaltverhalten verbunden ist, dass er durch hydrolisierbares ATP verhindert 
oder verlangsamt werden kann und dass Serin/Threonin Kinasen kritisch für die protektiven 
ATP Effekte sind. Publikation 4 ergab, dass Blutglukose und Serum Glukagon Spiegel in Cav2.3-
defizienten Mäusen im Vergleich zu Cav2.3-kompetenten Mäusen signifikant erhöht sind, 
während Zn2+ Depletion mit DEPC zu einem signifikanten Anstieg von Blutglukose und Serum 
Glukagon Spiegeln in Cav2.3-kompetenten aber nicht in Cav2.3-defizienten Mäusen führt. DEPC 
Behandlung führte außerdem zu einer schweren Glukoseintoleranz in Cav2.3-defizienten 
Mäusen, während die Glukosetoleranz in unbehandelten Cav2.3-defizienten sowie behandelten 
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und unbehandelten Cav2.3-kompetenten Mäusen unbeeinträchtigt war. In in vitro Versuchen 
stimulierte DEPC den Ca2+ Einfluss durch rekombinante Cav2.3 Kanäle in der Gegenwart von 
Zn2+ aber nicht in der Gegenwart des Zn2+ Komplexbildners CaEDTA. Publikation 5 ergab, dass 
KA rekombinante Cav2.3 Kanäle durch eine Umkehr Cu2+-induzierter Inhibition, die vermutlich 
auf Bildung stabiler Kainat-Cu2+ Komplexe beruht, auch in Abwesenheit funktioneller Glutamat 
Rezeptoren stimulieren könnte. Simulation der Rezeptor-unabhängigen Effekte von KA durch 
Applikation des Komplexbildners Tricin in der isolierten Rinderretina führte zur selektiven 
Abnahme in der Amplitude einer späten Komponente der elektroretinographischen b-Welle, für 
welche in früheren Arbeiten eine Stimulation durch genetische oder pharmakologische Ablation 
von Cav2.3 Kanälen gezeigt wurde. Publikation 6 ergab, dass die Zn2+-induzierten 
Veränderungen im Schaltverhalten von Cav2.3 Kanälen komplex sind und mehr als einen 
einzelnen Wirkmechanismus umfassen. Mittels Computersimulationen wurde gezeigt, dass die 
meisten, aber nicht alle, Effekte durch ein vereinfachtes Modell reproduziert werden können, bei 
dem Zn2+ Interaktion mit einer ersten Bindungstelle zu einer elektrostatischen Modifikation und 
mechanischen Verlangsamung eines der Spannungssensoren führt und Zn2+ Interaktion mit einer 
zweiten Bindungstelle von niedrigerer Affinität den Kanal blockiert und zu einer Verlangsamung 
des Öffnungs- und Schließverhaltens führt.  
Diskussion: Bezüglich der Zn2+-induzierten Modulation von Cav2.3 Kanälen deuten die 
Ergebnisse aus Publikation 6 auf komplexe Wechselwirkungen mit den vorherrschenden 
neuronalen und ionischen Bedingungen hin, welche die Zn2+ Wirkung beeinflussen und sogar 
umkehren könnten. So hängt der Gesamt Zn2+ Effekt auf Cav2.3 Kanäle aufgrund paralleler 
Veränderungen in der Spannungsabhängigkeit von Aktivierung und Inaktivierung stark vom 
Haltepotential ab, kann sowohl inhibierend als auch stimulierend sein und für mehrere Minuten 
nach Beendigung des Zn2+ Signals andauern. Neben einer möglichen Rolle für bestimmte 
Mechanismen der synaptischen Sensibilisierung und Plastizität könnten diese Effekte für die 
Regulation von Cav2.3 Kanälen in den Langerhans Inseln des Pankreas relevant sein, wo eine 
plötzliche Einstellung der Zn2+ Freisetzung aus β-Zellen als eines der Switch-off Signale für die 
Glukagon Freisetzung aus α-Zellen zu dienen scheint. Letztere Annahme wird durch die 
Ergebnisse in Publikation 4 untermauert, welche erste Belege für eine Rolle von Cav2.3 Kanälen 
für die Zn2+-vermittelte Inhibition der Glukagonfreisetzung unter hyperglykämischen 
Bedingungen liefern und zeigen, dass Cav2.3 Kanaldysfunktion, besonders in Kombination mit 
Zn2+-Defizienz, zu schweren Störungen der Glukosehomöostase führen könnte. Basierend auf 
den Ergebnissen der Publikationen 5 und 6 könnte eine Abnahme bzw. Umkehr der Zn2+ und 
Cu2+ vermittelten Inhibition von Cav2.3 Kanälen durch endogene (z.B. Glutamat) oder exogene 
(z.B. KA) Komplexbildner, mäßige Acidose oder Depolarisation des neuronalen 
Ruhemembranpotentials möglicherweise auch zur pro-konvulsiven Rolle dieser Kanäle 
beitragen, welche in früheren Arbeiten belegt wurde. Schließlich legen die Ergebnisse aus 
Publikation 3 nahe, dass Proteinphosphorylierung kritisch für die normale Funktion von Cav2.3 
Kanälen ist und ihre elektrophysiologischen Eigenschaften modifizieren könnte.    
Konklusion: Die in dieser Arbeit zusammengestellten Artikel liefern verschiedene neue 
Erkentnisse über die Mechanismen der reziproken Modulation von Cav2.3 Kanälen durch 
Spurenmetallkationen und Komplexbildner sowie erste Erkenntnisse zu ihrer möglichen 
Bedeutung unter (patho)physiologischen Bedingungen. Obwohl das in Publikation 6 erarbeitete 
Model als vorläufig anzusehen ist, bietet es eine quantitative Grundlage zum Verständnis der 
Effekte von Zn2+ auf Cav2.3 Kanäle und einen ersten Schritt in Richtung der Anwendung 
computerbasierter Methoden zur Prognose  der komplexen Wirkung von Zn2+ auf die neuronale 
Erregbarkeit. 
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1. Introduction 
1.1. Voltage-gated Ca2+ channels 
Under physiological conditions, intracellular Ca2+ levels are tightly controlled and 
maintained in the low nanomolar concentration range. Ca2+ can enter the cell through 
voltage-gated Ca2+ channels (VGCCs), which shape the electrical properties of excitable cells 
and represent the key link between electrical signals and non-electrical processes, such as 
transmitter release, peptide hormone secretion or gene transcription. The following sections 
will briefly describe their classification, structure and function. A more detailed description 
that goes beyond a mere recap of the literature is provided in publication 1 (Neumaier et al., 
2015). 
1.1.1. Classification and nomenclature 
Since their first recording in cardiomyocytes (Reuter, 1979, 1967), voltage-dependent Ca2+ 
currents in native membranes have been broadly classified into (I) low-voltage activated 
(LVA) currents which activate at membrane potentials near the resting level and display 
rapid inactivation kinetics and (ii) high-voltage activated (HVA) currents, which activate at 
somewhat more depolarized test potentials and display variable but typically less rapid 
inactivation kinetics (Carbone and Lux, 1984; Nowycky et al., 1985). Based on their 
biophysical and pharmacological properties, HVA currents were further subdivided into 
dihydropyridine-sensitive L-type (for long lasting), ω-conotoxin GVIA-sensitive N-type (for 
neuronal or neither T- nor L-type), ω -agatoxin IVA-sensitive P/Q-type (for Purkinje neurons) 
and partly SNX-482-sensitive R-type (for resistant or residual) currents, while LVA currents 
were assigned to a single group of T-type (for transient) currents (Llinás et al., 1992; 
Nowycky et al., 1985; Randall and Tsien, 1995; Tsien et al., 1987). Purification (Curtis and 
Catterall, 1984), reconstitution (Curtis and Catterall, 1986; Flockerzi et al., 1986) and 
molecular cloning (Tanabe et al., 1987) of the skeletal muscle Ca2+ channel in the late 1980s 
and subsequent homology screening of lambda-phage and cDNA libraries firmly established 
the existence of multiple, distinct Ca2+ channel α1-subunits (Catterall, 2011; Hille, 1992). They 
were originally named based on an alphabetical nomenclature, which assigned the letter S to 
the original skeletal muscle channel (i.e. α1S) and the letters A-F to subsequently identified α1-
subunits (Birnbaumer et al., 1994; Snutch et al., 1990; Snutch and Reiner, 1992). Today, 
VGCCs are classified based on amino acid sequence identity and named according to the 
same nomenclature used for other voltage-gated ion channels, where a given α1-subunit is 
identified by the principal permeating ion (i.e. Ca for Ca2+), the main physiological regulator 
(i.e. v for voltage) indicated as a subscript (i.e. Cav) and a numerical identifier that 
corresponds to one of three subfamilies (Cav1 through Cav3) and the order of discovery 
within that subfamily (Catterall et al., 2003; Ertel et al., 2000). Based on pharmacological and 
functional criteria, the Cav1 family (Cav1.1 through Cav1.4) has been convincingly linked to 
native L-type currents, the Cav2 family to native P/Q-type (Cav2.1), N-type (Cav2.2) and R-
type (Cav2.3) currents and the Cav3 family (Cav3.1 through Cav3.3) to native T-type currents.  
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1.1.2. Subunit composition 
Similar to other voltage-gated ion channels, native HVA channels are multi-subunit 
complexes comprised of a principal, transmembrane-spanning Cavα1-subunit, several 
auxiliary subunits of lower molecular weight and the ubiquitous intracellular Ca2+-sensor 
calmodulin (CaM), which associates with a CaM-binding domain in the cytoplasmic C-
terminal region. Expression levels and the properties of Cavα1-subunits vary with co-
expression of one of at least four Cavβ-subunits, one of at least four Cavα2δ-subunits and in 
some cases one of several putative Cavγ-subunits. Additional diversity arises from a number 
of possible splice variants and posttranslational modification of the Cavα1 or other subunits 
(Jones, 1998; Lacinová, 2005). LVA channels on the other hand lack the CaM-binding domain 
and are typically thought to consist only of a pore-forming Cavα1-subunit (Lacinová et al., 
1999; Lambert et al., 1997; Leuranguer et al., 1998).  
1.1.3. Structure 
As illustrated in Fig. 1, Cavα1-subunits are made up of four homologous repeats termed 
domains I through IV, each comprising six membrane-spanning helical segments (S1-S6) and 
a pore forming p-loop between S5 and S6 (Zhen et al., 2005). The first four segments of each 
domain have been shown to form the voltage-sensor modules (VSMs) responsible for 
coupling changes in membrane potential to channel opening. The remaining two segments 
make up most of the internal pore lining, with the p-loops forming the extracellular mouth of  
 
Figure 1. Subunit composition and transmembrane topology of high-voltage activated calcium channels. 
Inset shows quadrameric arrangement of homologous domains of the pore-forming α1 subunit at the cell 
membrane. For clarity, domain IV is shown aside from the membrane. Reprinted with permission from 
(Neumaier et al., 2015). 
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the pore and the Ca2+ selective filter region (Kim et al., 1993; Yang et al., 1993).  Cavβ-subunits 
are intracellular, hydrophilic proteins without transmembrane segments (Fig. 1), which bind 
to a high-affinity site located in the cytoplasmic linker between the first two homologous 
repeats of the Cavα1-subunit (Buraei and Yang, 2013). Cavα2δ-subunits are made up of two 
distinct subunits (α2 and δ), formed by post-translational cleavage of a single gene product 
and associated with each other via disulfide bonds (Ellis et al., 1988). As indicated in Fig. 1, 
the highly glycosylated α2-subunit resides on the extracellular side and is thought to be 
anchored in the plasma membrane by the smaller δ protein (Gurnett et al., 1996). 
1.1.4. Functional properties 
The classical view of voltage-gated ion channels assumes that transfer of ions across the 
membrane (permeation) is independent of the transitions between non-conducting and 
conducting states (gating) and vice versa. This assumption is conceptually useful and often 
necessary for interpretation of experimental findings, but there is convincing evidence for an 
interaction between gating and permeation in VGCCs (for details see publication 1). 
1.1.4.1. Voltage-dependent activation 
Activation of all voltage-gated ion channels involves charge-moving conformational changes 
that produce measurable gating currents and have been shown to depend on charged 
residues in the S2, S3 and especially S4 segments of all four domains (Hille, 1992; Vargas et 
al., 2012). A possible mechanism for the process based on models for activation of Shaker K+-
channels is shown in Fig. 2A & B. At resting membrane (i.e. hyperpolarized) potentials, the 
permeation pathway is occluded by parts of the S6 segments, which form a hydrophobic 
cavity that is inaccessible for ions. Depolarization forces the positively charged S4 segments 
to rotate or tilt through a protein-lined pathway formed by the rest of the VSM, which leads 
to relocation of the S5 and S6 segments with formation of a water-filled and ion permeable 
crevice. Evidence from mutational studies (Beyl et al., 2016; García et al., 1997) and optical 
tracking of voltage-sensor movement (Pantazis et al., 2014) indicates that activation of only 
two of the four non-identical VSM may be sufficient to drive channel opening in VGCCs.   
1.1.4.2. Voltage- and Ca2+-dependent inactivation 
The extent of Ca2+ entry during prolonged depolarization is limited by voltage- or Ca2+-
dependent inactivation, which may involve distinct conformational changes and can vary 
with the exact subunit composition. Voltage-dependent inactivation (VDI) of HVA channels 
has been linked to parts of the pore-forming segments and intracellular linkers (Hering et al., 
2000; Stotz et al., 2000)  and proposed to involve a ‘hinged lid’ mechanism, where docking of 
the I-II linker to the cytoplasmic ends of the S6 segments occludes the inner pore vestibule 
(Fig. 2C)(Stotz et al., 2004, 2000). The process appears to be state- rather than truly voltage-
dependent and is subject to modulation by co-expressed Cavβ-subunits, which may modify 
mobility of the I-II linker (Stotz et al., 2004). Ca2+-dependent inactivation is largely restricted 
to otherwise non-inactivating (Cav1.1-Cav1.4) or certain neuronal channels (Cav2.1 and 
Cav2.2) and thought to be induced by formation of Ca2+/CaM complexes (Budde et al., 2002). 
13 
 
  
Figure 2. Conformational changes during activation and inactivation of VGCCs. Cartoon illustrating 
possible mechanisms of channel activation and inactivation based on models of activation for Shaker K+-
channels and fast VDI of Cav2.3 VGCCs. Only two of the four homologous domains are shown. (A) At 
resting membrane potentials, the permeation pathway is occluded by regions of the S6 segments which 
form parts of the channel lumen, resulting in a hydrophobic cavity that is inaccessible for ions. (B) During 
membrane depolarization, the positively charged S4 segments (yellow) rotate and decrease their tilt (see 
inset), leading to changes in the relative position of other segments and formation of a water-filled crevice, 
in which ions can traverse the channel. (C) Upon prolonged depolarization, the intracellular linker between 
domains I and II (highlighted in red) docks to a site composed, in parts, of the S6 segments of domains II 
and III (see inset), thereby physically occluding the inner vestibule of the channel and terminating the flow 
of ions. Reprinted with permission from (Neumaier et al., 2015). 
1.1.4.3. Selective permeation 
Under physiological conditions, VGCCs are almost exclusively selective for Ca2+, with 
estimated rate coefficients for overall Ca2+ transfer of 7.5 x 107 M-1 s-1 for HVA channels (Hess 
et al., 1986) and 0.3-0.5 x 108 M-1 s-1 for LVA channels (Carbone and Lux, 1987; Lux et al., 
1990). Selectivity is mainly conferred by a conserved high-affinity Ca2+ binding site in the 
pore region, which is formed by a ring of glutamate (and in LVA channels aspartate) 
residues located at equivalent positions in each of the four p-loops (EEEE/EEDD-locus) (Cens 
et al., 2007; Cibulsky and Sather, 2000; Ellinor et al., 1995; Shuba, 2014; Talavera et al., 2001; 
Tang et al., 1993; Yang et al., 1993). Several mechanisms have been proposed to account for 
the apparent paradox of high-affinity binding and high conductance, most of which are 
based on a combination of ion-pore and ion-ion interactions in the permeation pathway. In 
the classical ‘stairstep model’, low-affinity binding sites flanking the EEEE/EEDD-locus are 
thought to allow for stepwise entry and exit of Ca2+ ions from the pore, thereby lowering the 
energy required for dissociation from the high-affinity binding site (Dang and McCleskey, 
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1998). In the ‘car wash model’, the EEEE/EEDD-locus is thought to form a flexible, multi-ion 
binding site that can accommodate a single Ca2+ ion with high-affinity or multiple Ca2+ ions 
with lower affinity (Yang et al., 1993). Occupation by more than one Ca2+ ion could 
destabilize high-affinity binding due to electrostatic repulsion (Almers and McCleskey, 1984; 
Hess and Tsien, 1984), competition for binding moieties (Armstrong and Neyton, 1991; Yang 
et al., 1993) and / or conformational changes (Lux et al., 1990; Mironov, 1992). Support for a 
mechanism akin to the stairstep model has been provided by crystallographic data on the 
Ca2+-selective model channel CavAb, which was derived from the bacterial sodium channel 
NavAB. In this channel and several related constructs, the selectivity filter is formed by a 
central high-affinity DDDD-locus and two flanking low-affinity sites (Fig. 3A-C), which are 
at least partly conserved in human VGCCs (Fig. 3D). 
 
 
Figure 3. Functional organization of the selectivity filter in voltage-gated calcium channels. (A, B) 
Cartoon representation of the crystal structure of pAsp181Asn (a construct closely related to CavAb) 
showing three of the four identical domains with Ca2+ ions (green) bound to all three coordination sites in 
the selectivity filter. Note that the crystal structure likely reflects a mixed population of channels, in which 
either the central or the two flanking coordination sites are occupied. (C) State-diagram showing the two 
low energy states of occupation and possible intermediates. (D) Sequence alignment of residues making up 
the selectivity filter in CavAb and its derivatives with the corresponding residues in cloned human voltage-
gated calcium channels. Conserved residues are highlighted in bold. Reprinted with permission from 
(Neumaier et al., 2015). 
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1.1.4.4. Run-up and run-down 
Electrophysiological recordings associated with dialysis of the cytoplasm or excision of cell 
patches are almost invariably hampered by time-dependent changes in voltage-gated ion 
channel function. The most well-known form of these phenomena is a progressive decline of 
voltage activated currents after breakthrough into the whole-cell configuration (run-down). 
The process is typically thought to result from dilution of the cellular contents by the pipette 
solution and an associated loss of second messengers and intracellular signaling cascades 
(Becq, 1996). In some cases, run-down is preceded by a transient current facilitation, which 
could reflect a relief of tonic suppression and / or voltage- and time-dependent repriming 
(i.e. recovery from inactivation) (Elhamdani et al., 1995, 1994; Tiaho et al., 1993). While they 
remain a major obstacle for studies on the pharmacology and physiology of voltage-gated 
channels, these time-dependent changes can also provide insight into the modulation of 
channels in intact cells. For this reason, the hallmarks and mechanisms of run-down of L-
type Ca2+ currents have been subject to numerous investigations (Belles et al., 1988; Chad and 
Eckert, 1986; Hao et al., 1999; Hescheler et al., 1988; Martini et al., 2000; McDonald et al., 
1994; Mironov and Lux, 1991). Probably owing to their minor contribution to the total Ca2+ 
current in many non-neuronal cells, much less work has been devoted to characterizing the 
process in other HVA VGCCs. For example, native R-type currents, which are mainly 
mediated by Cav2.3-type VGCCs, are well known to exhibit both run-up and run-down 
(Almog and Korngreen, 2009; Benquet et al., 1999; Cota, 1986; Hilaire et al., 1997). Although 
some findings indicate that run-down may be associated with changes in R-type-like Ca2+ 
channel gating (Cota, 1986), the rapid loss of these currents in conventional 
electrophysiological recordings has generally prevented further characterization of the 
phenomenon in native cells. Some of the experiments performed in the present work were 
also hampered by time-dependent changes in Cav2.3 channel currents, which prompted us to 
investigate the process in more detail. The results of these experiments allowed us to develop 
experimental conditions that significantly delayed the occurrence of run-down and provided 
interesting insights into the importance of protein phosphorylation for the normal function 
of Cav2.3 channels, as described in more detail in publication 3 (Neumaier et al., 2018b).  
1.2. Cav2.3 voltage-gated Ca
2+ channels 
Cav2.3-type VGCCs are the only molecular counterpart of native R-type currents so far 
identified and remain one of the most enigmatic members of the family of VGCCs, not least 
because they share biophysical properties with both HVA (high activation threshold; large 
single channel conductance; rapid deactivation kinetics) and LVA (equal permeability to Ca2+ 
and Ba2+; fast inactivation kinetics) channels (Bourinet et al., 1996; Soong et al., 1993; 
Wakamori et al., 1994). They are resistant towards most commonly used organic Ca2+ channel 
antagonists but highly sensitive to certain divalent trace metal ions (Zn2+, Cu2+ and Ni2+), 
which has been linked to non-conserved histidine residues on the external side of the domain 
I VSM (Kang et al., 2007; Shcheglovitov et al., 2012). In addition, Cav2.3 channels are sensitive 
to the tarantula toxin SNX-482 (IC50=20-60 nM), which is a relatively selective inhibitor when 
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compared to other VGCCs, but has been shown to be even more effective in suppressing A-
type K+-currents mediated by Kv4.3 channels (IC50<3 nM) (Kimm and Bean, 2014).   
1.2.1. Expression and general function 
Cav2.3 channel expression is most prominent throughout the central and peripheral nervous 
system (Grabsch et al., 1999; Schneider et al., 1994; Soong et al., 1993; Williams et al., 1994), 
but has also been detected in neuroendocrine (Grabsch et al., 1999; Pereverzev et al., 2002b; 
Vajna et al., 1998), cardiovascular (Galetin et al., 2013), reproductive (Cohen et al., 2014; 
Wennemuth et al., 2000), and gastrointestinal tissues (Grabsch et al., 1999). Insight into the 
functional roles of Cav2.3 channels has been facilitated by the generation of Cav2.3-deficient 
mice, which exhibit no major pathologies but are characterized by altered spatial memory 
(Kubota et al., 2001) and nociception (Saegusa et al., 2000), increased anxiety (Lee et al., 2002), 
cardiac arrhythmias and impaired autonomic control (Galetin et al., 2013; Weiergräber et al., 
2005), reduced susceptibility to chemically induced seizures and excitotoxicity (Dibué-Adjei 
et al., 2017; Weiergräber et al., 2007) and certain alterations in glucose homeostasis (Matsuda 
et al., 2001; Pereverzev et al., 2002a). Based on this relatively subtle phenotype and their 
preferential expression in rhythmically active tissues, a general function of Cav2.3 channels 
has been proposed to involve fine-tuning of rhythmogenesis in oscillatory networks 
(Schneider et al., 2015).  
1.2.2. Role of Cav2.3 channels in the brain 
In the CNS, highest densities of Cav2.3 channels can be detected in the hippocampus and 
other limbic regions, in the retina and in cortical neurons (Sochivko et al., 2002; Weiergräber 
et al., 2006b). They are expressed both presynaptically (Day et al., 1996) and postsynaptically 
(Day et al., 1996; Yokoyama et al., 1995) and have been shown to be involved in transmitter 
release and neuronal plasticity (Bloodgood and Sabatini, 2007; Dietrich et al., 2003; Gasparini 
et al., 2001; Yasuda et al., 2003), somatodendritic integration and action potential burst firing 
(Christie et al., 1995; Kavalali et al., 1997; Magee and Carruth, 1999; Magee and Johnston, 
1995). In addition, Cav2.3 channels are the third most extensively phosphorylated ion 
channels in mouse brain (Cerda et al., 2011) and depolarization has been shown to trigger 
bulk changes of their phosphorylation state in intact hippocampal slices (Hell et al., 1995). In 
the retina, Cav2.3 channels appear to be involved in GABA-ergic reciprocal inhibition of rod 
bipolar cells (Siapich et al., 2009), and genetic ablation or pharmacological suppression of 
these channels have been shown to selectively enhance a late b-wave component of the 
eletroretinogram (ERG) (Alnawaiseh et al., 2011; Lüke et al., 2005; Siapich et al., 2010). The 
exact physiological relevance of Cav2.3 channels in most other brain regions remains elusive, 
but there is increasing evidence for their involvement in a number of pathophysiological 
conditions. With regard to human patients, recent findings have implicated de novo gain-of-
function mutations in these channels with developmental and epileptic encephalopathies, 
which are characterized by intractable seizures, abundant epileptiform EEG activity and 
developmental impairments (Carvill, 2019; Helbig et al., 2018). A pro-ictogenic role of Cav2.3 
channels in convulsive generalized tonic-clonic and hippocampal seizures has also been 
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demonstrated in a number of animal studies, where their genetic ablation significantly 
reduced the susceptibility to kainic acid (KA)-induced seizures and neurodegeneration 
(Dibué-Adjei et al., 2017; Weiergräber et al., 2007, 2006a). In addition, treatment with the 
broad-spectrum antiepileptic drugs lamotrigine (LTG) or topiramate (TPM), both of which 
have been shown to inhibit cloned Cav2.3 channels (Hainsworth et al., 2003; Kuzmiski et al., 
2005), significantly reduced KA-induced seizures in wildtype but not Cav2.3-deficient mice 
(Dibué-Adjei et al., 2017), suggesting that Cav2.3 channels could be an important target for 
current antiepileptic treatments. 
1.2.3. Role of Cav2.3 channels for glucose homeostasis 
Animal studies have linked Cav2.3 VGCCs to α-cell glucagon secretion (Pereverzev et al., 
2005), β-cell insulin secretion (Jing et al., 2005; Matsuda et al., 2001; Pereverzev et al., 2002a) 
and δ-cell somatostatin (SST) secretion (Zhang et al., 2007), suggesting that these channels 
are critically involved in the regulation of blood glucose levels. Under hyperglycemic 
conditions, glucose homeostasis is primarily maintained by glucose-stimulated insulin 
secretion (GSIS) from pancreatic β-cells, which is thought to involve a triggering pathway of 
fast insulin secretion (first phase insulin response), and an amplifying pathway of sustained 
release (second phase insulin response). The molecular mechanisms underlying fast GSIS are 
relatively well established and have been shown to involve β-cell glucose uptake and 
metabolism followed by depolarization due to ATP-dependent closure of KATP channels, 
which triggers Ca2+-influx through Cav1.2 channels and secretion of a readily releasable pool 
of insulin vesicles. The sustained insulin response is much less well understood but thought 
to involve mobilization of a reserve pool of insulin vesicles for release. Genetic or 
pharmacological ablation of Cav2.3 channels selectively reduces the second phase insulin 
response in mice (Jing et al., 2005; Pereverzev et al., 2005), suggesting that β-cell Cav2.3 
channels are involved in the mobilization of insulin vesicles from the reserve pool. They 
could also play a role for the paracrine effects of SST released from δ-cells, as SST suppresses 
cloned Cav2.3 channels (Mehrke et al., 1997) and SNX-482 has been shown to prevent SST 
inhibition of insulin secretion from insulinoma cells (Mergler et al., 2008). According to the 
intra-islet insulin hypothesis, insulin released into the periportal circulation is carried to 
nearby α-cells, where it provides tonic suppression of glucagon secretion during 
hyperglycemia, while cessation of insulin secretion during hypoglycemia could serve as a 
switch-off signal that initiates α-cell glucagon secretion (Banarer et al., 2002; Maruyama et al., 
1984). Interestingly, Cav2.3 channels appear to be important for the former (i.e. suppression 
of glucagon release during hyperglycemia) but not directly involved in the latter (i.e. release 
of glucagon during hypoglycemia), as glucose-induced suppression of glucagon release is 
severely impaired or even reversed in Cav2.3-deficient mice (Jing et al., 2005), isolated islets 
from Cav2.3-deficient mice (Jing et al., 2005; Pereverzev et al., 2005) and SNX-482 treated 
islets from wildtype mice (Göpel et al., 2004; Jing et al., 2005) whereas SNX-482 fails to 
reduce glucagon secretion from wildtype islets in low glucose. As discussed in more detail in 
section 1.3.3 and assessed experimentally in publication 4 (section 2.4), there is increasing 
evidence that Zn2+ co-released with insulin from pancreatic β-cells could serve as an 
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additional, non-insulin signal for crosstalk to neighboring α-cells, which might exert its 
action in part by suppressing Cav2.3 channels. The pathophysiological relevance of these 
findings is corroborated by several studies linking variants in the gene encoding Cav2.3 
channels to impaired glucose homeostasis in human T2DM patients (Holmkvist et al., 2007; 
Muller et al., 2007; Trombetta et al., 2012).  
1.2.4. Role of Cav2.3 channels in the vascular system 
There is also evidence for a role of Cav2.3 channels in the vascular system, although again 
mainly in the context of certain pathophysiological conditions. For example, hemoglobin, 
which can be released into the brain extracellular space during hemorrhagic stroke, has been 
shown to induce up-regulation of Cav2.3 channels in cerebral vessels (Ishiguro et al., 2005) 
and there is evidence for an involvement of these channels in delayed cerebral vasospasm 
and ischemia after subarachnoid hemorrhage (Ishiguro and Wellman, 2008). In addition, 
work from our lab shows that unconjugated bilirubin (UCB), a degradation product of 
hemoglobin, alters Cav2.3 channel function in a heterologous expression system and 
attenuates transretinal signaling in the isolated retina from wildtype but not Cav2.3-deficient 
when applied at pathophysiologically relevant UCB:albumin molar ratios (Albanna et al., 
2019, 2017).  
1.3. Endogenous trace metal ions 
Trace metal ions like Zn2+ and Cu2+ are key structural components of numerous proteins and 
co-factors for enzymes involved in cellular respiration, catecholamine synthesis and 
antioxidant defense (Anzellotti and Farrell, 2008; Frederickson et al., 2005). In addition to 
their established structural and catalytic functions, endogenous Zn2+ and Cu2+ are 
increasingly recognized as potential modulators of neuronal transmission (Frederickson et 
al., 2005, 2000; Mathie et al., 2006) and synaptic plasticity (Pan et al., 2011). As noted above, 
Zn2+ has also been identified as a candidate auto- and / or paracrine signal for intra-islet 
crosstalk in the pancreas, which could be critically involved in the regulation of blood 
glucose homeostasis by insulin and glucagon (Ishihara et al., 2003).  
1.3.1. Trace metal speciation 
The biological effects of trace metal ions are determined by their chemical speciation, which 
is defined as the distribution among all free and ligand-bound species in solution (for details 
see publication 2). Under physiological conditions, the majority of Zn2+ and Cu2+ is tightly 
bound by a range of metalloprotein ligands, so that the pool that remains 
thermodynamically and kinetically accessible (i.e. loosely-bound) is usually orders of 
magnitude below the total concentration. This is especially important in the intracellular 
compartment, where even moderate increases in the loosely-bound Zn2+ or Cu2+ level are 
deleterious and ultimately associated with cell death. A detailed review of the tightly 
regulated intracellular trace metal homeostasis is beyond the scope of this work and can be 
found elsewhere (Colvin et al., 2010, 2003; Krężel and Maret, 2006). The present article will 
focus on the action of extracellular trace metal ions, noting that there is usually a large 
concentration-gradient favoring their passive entry into postsynaptic neurons. The latter is 
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under study as potential signaling pathway (Li et al., 2001) and important mechanism that 
may contribute to hippocampal neurodegeneration under certain pathophysiological 
conditions (Frederickson et al., 1988; Mathie et al., 2006). With regard to the extracellular 
compartment, an important implication of chemical speciation is that loosely-bound trace 
metal concentrations could be subject to modulation by a number of small organic molecules 
that are capable of acting as trace metal chelators. This is exemplified in publication 5 
(Neumaier et al., 2018a), where we provide in vitro evidence for a receptor-independent 
mechanism of Cav2.3 channel modulation by the excitatory amino acid KA that involves 
reversal of Cu2+-induced suppression. Additional implications are that suitable trace metal 
chelators can be used to antagonize the effects of endogenous trace metals, and that proper 
metal ion buffering should be used in experiments with metal ion-sensitive targets. The latter 
is important because even highly purified reagents contain small amounts of trace metal 
ions, so that estimated levels of Zn2+, Cu2+ and / or other unwanted metal ions in typical 
physiological solutions are in the nano- to micromolar concentration range (for details see 
publication 2). As described in one of the later sections, this may be sufficient for significant 
tonic suppression of certain Cavα1-subunits and could therefore also influence experimental 
findings. 
1.3.2 Zn2+ and Cu2+ signaling in the brain 
While 90% of total brain Zn2+ is tightly bound to zinc metalloproteins, much of the remaining 
10% forms a loosely-bound pool located in the presynaptic vesicles of so-called zinc-enriched 
neurons (Frederickson et al., 2000; Mathie et al., 2006). These neurons are not associated with 
a single neurotransmitter and have been shown to release Zn2+ both spontaneously and in an 
activity-dependent manner. Similar pools of loosely-bound Cu2+ that can be released 
following membrane depolarization have been detected in certain neurons that appear to be 
primarily associated with glutaminergic or adrenergic transmission (Kardos et al., 1989; Ono 
and Cherian, 1999; Sato et al., 1994). The distribution of loosely-bound Zn2+ and Cu2+ in the 
brain is not uniform, and highest concentrations are located in specific forebrain areas that 
include the hippocampus and other limbic regions, the neocortex and the retina (Anastassov 
et al., 2014, 2013; Charton et al., 1985; Hartter and Barnea, 1988; Kardos et al., 1989). Under 
physiological conditions, estimated resting or ‘tonic’ levels in the brain extracellular fluid are 
in the order of 5-25 nM for loosely-bound Zn2+ (Frederickson et al., 2006) and 0.1-0.8 µM for 
loosely-bound Cu2+ (Mathie et al., 2006). These values are frequently exceeded at mossy fiber 
synapses, where Zn2+ concentrations have been estimated to be in excess of 10-20 µM during 
basal synaptic activity and >100 µM during repetitive electrical stimulation or periods of 
intense activity (Kardos et al., 1989; Mathie et al., 2006; Vogt et al., 2000). During KA-induced 
epileptiform (or ictal-like) discharges, Zn2+ levels in the order of 300 µM have been estimated 
to be reached in the extracellular space (Assaf and Chung, 1984). Released metal ions could 
modulate neuronal activity through effects on a variety of voltage- and ligand-gated ion 
channels (Elinder and Arhem, 2003; Neumaier et al., 2015), which has made it difficult to 
predict the net action of Zn2+ and Cu2+. As such, their exact functional relevance in the brain 
remains controversial, although a number of experimental observations indicate that 
20 
 
especially Zn2+ could dampen excitability in limbic regions and serve as an intrinsic 
anticonvulsant. In mice, synaptic release and extracellular accumulation of Zn2+ have been 
shown to limit propagation of cortical spreading depression in vitro and in vivo (Aiba et al., 
2012). Zn2+ chelation or deficiency increases the susceptibility to KA-induced seizures 
(Takeda et al., 2005, 2003) and induces excitotoxicity and convulsions in healthy rats (Blasco-
Ibáñez et al., 2004) and rats subjected to non-lesioning over-excitation (Domínguez et al., 
2003). In addition, Zn2+ treatment has been shown to reduce dentate granule cell 
hyperexcitability in epileptic human patients (Williamson and Spencer, 1995). On the other 
hand, massive release of synaptic Zn2+ and its translocation into postsynaptic neurons has 
been proposed as a mechanism for hippocampal neurodegeneration, which occurs following 
seizures, ischemia or traumatic brain injury (Frederickson et al., 1988; Mathie et al., 2006). 
However, the presynaptic origin of Zn2+ involved in this process remains controversial, since 
postsynaptic Zn2+ accumulation and cell death after KA-induced seizures or traumatic brain 
injury were the same or even increased in mice lacking Zn2+ transporter 3 (ZnT3), which are 
completely devoid of vesicular Zn2+ (Doering et al., 2010; Lee et al., 2000). Because 
intracellular metal ion buffering and sequestration are tightly coupled to the cells energetic 
and redox state, deleterious levels of Zn2+ could also be released from metallothioneins and 
other reservoirs located in damaged postsynaptic neurons themselves. The interpretation of 
experimental findings is further complicated by the fact that fluorescent probes used for Zn2+ 
staining have been shown to adhere non-specifically to the membrane of injured neurons 
(Hawkins et al., 2012). That notwithstanding and considering the many potential targets, it 
seems reasonable to assume that the effects of Zn2+ (and Cu2+) could include both 
compensatory (i.e. neuroprotective) and causative (i.e. neurotoxic) actions and that a 
complex interplay of factors determines their respective contribution under 
pathophysiological conditions. As exemplified in publication 6 (section 2.6), the magnitude 
and even direction of Zn2+ effects on a single target like Cav2.3 channels can be affected by 
factors such as the resting membrane potential or the exact ionic conditions.  
1.3.3. Zn2+ signaling in pancreatic islets 
It is well known that Zn2+ is present at high (millimolar) concentrations in β-cell insulin 
secretory vesicles and required for proper insulin biosynthesis, maturation and secretion 
(Emdin et al., 1980; Li, 2014). During the maturation process, insulin mono- and dimers 
aggregate in the presence of Zn2+ to form 2Zn-hexameric complexes, which significantly 
lowers their solubility and causes crystallization within the vesicles (Emdin et al., 1980; Li, 
2014). During hyperglycemia, the Zn2+-insulin complexes are released into the periportal 
circulation, where the higher pH of blood favors their rapid dissociation into free Zn2+ and 
insulin monomers (Li, 2014; Robertson et al., 2011). The resulting local Zn2+ concentrations in 
the extracellular space are estimated to be in the order of several hundred μM (Kim et al., 
2000), so that nearby cells are exposed to high levels of unbound Zn2+. As such, Zn2+ has long 
been recognized as a candidate signal for non-insulin paracrine crosstalk to neighboring α-
cells (Ishihara et al., 2003), and a number of recent findings provide support to this idea. For 
example, Zn2+ was reported to suppress pyruvate- or glucose-induced glucagon release in 
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static secretion and electrophysiological experiments with isolated murine islets and purified 
α-cells (Franklin et al., 2005; Gyulkhandanyan et al., 2008). Moreover, Zn2+ but not Zn2+-free 
insulin, has been shown to inhibit α-cell glucagon secretion in the perfused rat pancreas 
(Robertson et al., 2011; Zhou et al., 2007). It should also be noted however, that some studies 
failed to detect Zn2+-induced suppression of glucagon secretion (Ramracheya et al., 2010; 
Ravier and Rutter, 2005), so that the topic remains a matter of heated debate. Identification of 
Zn2+ targets expressed in α-cells and directly involved in glucagon secretion could evidently 
help to resolve these discrepancies and strengthen understanding of the role of Zn2+ for intra-
islet crosstalk. In publication 4, we provide in vitro and in vivo evidence for a role of Cav2.3 
channels as targets for the putative Zn2+-induced suppression of α-cell glucagon secretion. In 
addition and consistent with this idea, results obtained in publication 6 indicate that sudden 
cessation of Zn2+ supply could not only reverse suppression but also transiently stimulate 
Ca2+ influx through Cav2.3 channels under certain conditions. 
1.3.4. Metal ion effects on voltage-gated Ca2+ channels 
The function of all voltage-gated ion channels is more or less effectively altered by changes 
in the concentration of divalent cations, although the underlying mechanisms can vary 
considerably. They may be broadly classified into three general groups, which comprise (i) 
electrostatic effects of metal ions in the bulk solution (surface charge screening, Fig. 3A) or 
bound to charged regions on the channel surface (surface charge binding, Fig. 3B), which 
alter the local potential sensed by the VSMs, (ii) blocking effects of metal ions bound to intra-
pore sites, which physically occlude the permeation pathway (pore block, Fig. 3C) and (iii) 
non-electrostatic effects of metal ions bound to specific metal-binding sites (allosteric 
modulation, Fig. 3D). Under physiological conditions, surface charge effects are mainly of 
experimental relevance, as they are predicted to become significant only at supra-
physiological (i.e. high micro- to millimolar) trace metal concentrations. A notable exception 
may be the retina, where surface charge effects on VGCCs have been proposed to play a 
physiological role (Cadetti et al., 2004). The blocking action of Zn2+ and other trace metal ions 
was investigated in early single-channel studies in mouse myotubes, which found that Zn2+ 
blocks L-type currents carried by 110 mM Ba2+ in a weakly voltage-dependent manner, with 
half-maximal inhibition at 0 mV by approximately 500 µM nominal Zn2+ (Winegar and 
Lansman, 1990). Most later studies on the effects of Zn2+ have been done using the whole-cell 
configuration of the patch-clamp technique, which has the advantage that recordings can be 
performed with much lower (i.e. near physiological) concentrations of charge carrying ions. 
However, separation of effects mediated by the different mechanisms of action described 
above remains a non-trivial task, since all of them may contribute to the net action observed 
in macroscopic current recordings. In addition, few studies have been performed using metal 
ion-buffered solutions, and comparison of the available data is further complicated by 
differences in the experimental conditions, the exact tissue or subunit compositions studied 
and the electrophysiological parameters used to quantify suppression. For example, nominal 
Zn2+ concentrations which have been reported to produce half- maximal suppression of  
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Figure 4. Mechanisms of modulation of voltage-gated calcium channels by polyvalent inorganic cations. 
Sketch of the pore-forming α1-subunit in a closed conformation, showing two of the four homologous 
domains with their voltage-sensor modules (S4 segments highlighted in yellow) and local charges on the 
channel surface (green). (A) Multivalent cations (M2+ / M3+, orange) in solution can screen charges on the 
channel surface, thereby electrostatically reducing the local potential sensed by the voltage-sensors (B) 
Some cations can electrostatically decrease the total surface charge density by directly binding to and 
neutralizing certain surface charges, producing a more pronounced reduction in the local potential. (C) 
Most di- and trivalent metal ions can bind to sites at or within the pore region (pore block), thereby 
physically occluding the permeation pathway. (D) Some VGCCs have been shown to possess high-affinity 
allosteric metal binding-sites on their domain I voltage-sensor. Reprinted with permission from (Neumaier 
et al., 2015). 
native HVA currents range from 20-30 µM in acutely dissociated cortical neurons 
(Magistretti et al., 2003) or 70 µM in DRG neurons (Büsselberg et al., 1994) to 210 µM in 
cultured cortical neurons (Kerchner et al., 2000) or 250 µM in acutely dissociated pelvic 
neurons (Jeong et al., 2003). The effects of Zn2+ (and in some cases Cu2+) on individual Cavα1-
subunits have been studied in a number of recombinant expression studies, which are 
summarized in detail in publication 1. With regard to cloned Cav2.3 channels, half-maximal 
suppression of currents carried by 5 mM Ca2+ was observed at 1.3 µM Zn2+ or 18 nM Cu2+ 
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when experiments were performed using metal ion-buffered solutions. In addition, 
(sub)micromolar concentrations of Zn2+, Cu2+ and Ni2+ produced depolarizing shifts in 
channel voltage-dependence, a reduced sensitivity towards depolarization and a 
pronounced slowing of macroscopic activation (Kang et al., 2007; Shcheglovitov et al., 2012; 
Zamponi et al., 1996) resembling their action on native R-type currents in cortical (Castelli et 
al., 2003; Magistretti et al., 2003) and DRG neurons (Shcheglovitov et al., 2012). Molecular 
cloning studies identified three histidine residues located in the IS1-IS2 (His111) and IS3-IS4 
(His179 and His183) loops, which are not conserved in other HVA channels and thought to 
form a high-affinity extracellular binding pocket for certain divalent cations (Kang et al., 
2007; Shcheglovitov et al., 2012). Since Zn2+, Cu2+ and Ni2+ also alter activation gating in HVA 
channels lacking critical histidine residues (Castelli et al., 2003; Magistretti et al., 2003; 
Zamponi et al., 1996), it remains to be determined if additional metal binding sites exist or if 
the gating changes described above are exclusively related to the putative metal binding site 
in domain I. This and some other open questions are addressed in publication 6, which 
provides experimental evidence for the idea that multiple sites are involved in the effects of 
Zn2+ on Cav2.3 channel gating and proposes a model that can account for most, but not all of 
these effects. 
1.4. Aims of the present work 
The general aim of the present work was to shed some light on the exact mechanisms of Zn2+- 
and Cu2+-induced Cav2.3 channel modulation and their potential relevance under normal and 
pathophysiological conditions. In publication 1, we used crystallographic data of the Ca2+-
selective bacterial model channel CavAb as a framework to analyze eukaryotic VGCC 
structure, function and modulation by inorganic cations. In publication 2, we assessed the 
methodical difficulties of metal ion-buffering in physiological solutions, developed general 
protocols for preparation and use of (multi) metal ion-buffered solutions and experimentally 
verified the critical importance of proper metal ion-buffering. In publication 3, we used 
conventional and perforated patch-clamp recordings together with different inhibitors and 
cytosolic factors to identify signaling cascades involved in Cav2.3 channel run-down during 
cell dialysis, which was critical to improve the stability of recordings for the detailed 
assessment of Zn2+ effects described in publication 6 (see below). In publication 4, we 
compared the effects of Zn2+ chelation on glucose homeostasis and peptide hormone 
secretion in Cav2.3-deficient and wildtype mice to determine if Zn2+-inhibition of Cav2.3 
channels contributes to the suppression of glucagon secretion during hyperglycemia. In 
publication 5, we used whole-cell patch-clamp recordings in stably transfected HEK293 cells 
and ex vivo electroretinographic recordings from the bovine retina to characterize a receptor-
independent but Cu2+-dependent mechanism of Cav2.3 channel modulation by KA. Finally, 
in publication 6, we analyzed the concentration-dependent effects of Zn2+ as a prototype 
redox-inert trace metal ion on cloned Cav2.3 channel function and developed a semi-
mechanistic Markov model capable of reproducing most salient features of current through 
these channels in the absence and presence of physiologically relevant Zn2+ concentrations.  
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2. Results 
2.1. Publication 1: Progress in Neurobiology 129:1-36. 
 
Voltage-gated calcium channels: Determinants of channel function and 
modulation by inorganic cations. 
Felix Neumaier, Maxine Dibué-Adjei, Jürgen Hescheler, Toni Schneider 
 
Abstract: 
Voltage-gated calcium channels (VGCCs) represent a key link between electrical signals and 
non-electrical processes, such as contraction, secretion and transcription. Evolved to achieve 
high rates of Ca2+-selective flux, they possess an elaborate mechanism for selection of Ca2+ 
over foreign ions. It has been convincingly linked to competitive binding in the pore, but the 
fundamental question of how this is reconcilable with high rates of Ca2+ transfer remains 
unanswered. By virtue of their similarity to Ca2+, polyvalent cations can interfere with the 
function of VGCCs and have proven instrumental in probing the mechanisms underlying 
selective permeation. Recent emergence of crystallographic data on a set of Ca2+-selective 
model channels provides a structural framework for permeation in VGCCs, and warrants a 
reconsideration of their diverse modulation by polyvalent cations, which can be roughly 
separated into three general mechanisms: (I) long-range interactions with charged regions on 
the surface, affecting the local potential sensed by the channel or influencing voltage-sensor 
movement by repulsive forces (electrostatic effects), (II) short-range interactions with sites in 
the ion-conducting pathway, leading to physical obstruction of the channel (pore block), and 
in some cases (III) short-range interactions with extracellular binding sites, leading to non-
electrostatic modifications of channel gating (allosteric effects). These effects, together with 
the underlying molecular modifications, provide valuable insights into the function of 
VGCCs, and have important physiological and pathophysiological implications. Allosteric 
suppression of some of the pore-forming Cavα1-subunits (Cav2.3, Cav3.2) by Zn2+ and Cu2+ 
may play a major role for the regulation of excitability by endogenous transition metal ions. 
The fact that these ions can often traverse VGCCs can contribute to the detrimental 
intracellular accumulation of metal ions following excessive release of endogenous Cu2+ and 
Zn2+ or exposure to non-physiological toxic metal ions. 
Contributions to Publication 1: 
I independently reviewed the literature and conceptualized the article, performed all 
sequence alignments, calculations and simulations described in the text and shown in the 
figures, created all tables and figures, wrote the manuscript and handled the submission and 
revision process. I was also chosen to create the cover art for the corresponding issue of 
Progress in Neurobiology. 
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2.2. Publication 2: Acta Physiologica 222(3): e12988. 
 
A practical guide to the preparation and use of metal ion-buffered systems 
for physiological research. 
Felix Neumaier, Serdar Alpdogan, Jürgen Hescheler, Toni Schneider 
 
Abstract: 
Recent recognition that mobile pools of Zn2+ and Cu2+ are involved in the regulation of 
neuronal, endocrine and other cells has stimulated the development of tools to visualize and 
quantify the level of free trace metal ions. Most of the methods used to measure or control 
loosely bound metals require reference media that contain exactly defined free 
concentrations of the target ions. Despite the central importance of proper metal ion 
buffering, there is still a lack of international standards and beginners in the field may have 
difficulties finding a coherent description of how to prepare trace metal ion buffers, 
especially when experiments are to be performed in multimetal systems. To close this gap, 
we provide a guide for the design, preparation and use of metal ion buffered systems that 
facilitate immediate application under physiologically relevant ionic conditions. 
Thermodynamic and kinetic concepts of chemical speciation as well as general protocols and 
specific examples are outlined for the accurate preparation of single- and dual-metal ion 
buffers. In addition, experiments have been performed with FluoZin-3 to illustrate that metal 
ion-buffered systems are required for reliable preparation of nanomolar Zn2+ solutions and 
that dual-metal ion buffers can be used to calibrate suitable fluorescent Zn2+ sensors in the 
presence of millimolar Ca2+ concentrations. Together, the information provided should 
sensitize readers to the many potential pitfalls and uncertainties that exist when working 
with physiologically relevant concentrations of trace metal ions and enable them to 
formulate their own metal ion buffers for most in vitro applications. 
 
Contributions to Publication 2: 
I independently reviewed the literature and conceptualized the article, developed the 
protocols and performed the experiments with FluoZin-3, created all tables and figures, 
wrote the manuscript and handled the submission and revision process. 
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2.3. Publication 3: Journal of General Physiology 150(3): 491-510. 
 
Protein phosphorylation maintains the normal function of cloned human 
Cav2.3 channels. 
Felix Neumaier, Serdar Alpdogan, Jürgen Hescheler, and Toni Schneider 
Abstract: 
R-type currents mediated by native and recombinant Cav2.3 voltage-gated Ca2+ channels 
(VGCCs) exhibit facilitation (run-up) and subsequent decline (run-down) in whole-cell 
patch-clamp recordings. A better understanding of the two processes could provide insight 
into constitutive modulation of the channels in intact cells, but low expression levels and the 
need for pharmacological isolation have prevented investigations in native systems. Here, to 
circumvent these limitations, we use conventional and perforated-patch-clamp recordings in 
a recombinant expression system, which allows us to study the effects of cell dialysis in a 
reproducible manner. We show that the decline of currents carried by human Cav2.3+β3 
channel subunits during run-down is related to adenosine triphosphate (ATP) depletion, 
which reduces the number of functional channels and leads to a progressive shift of voltage-
dependent gating to more negative potentials. Both effects can be counteracted by 
hydrolysable ATP, whose protective action is almost completely prevented by inhibition of 
serine/threonine but not tyrosine or lipid kinases. Protein kinase inhibition also mimics the 
effects of run-down in intact cells, reduces the peak current density, and hyperpolarizes the 
voltage dependence of gating. Together, our findings indicate that ATP promotes 
phosphorylation of either the channel or an associated protein, whereas dephosphorylation 
during cell dialysis results in run-down. These data also distinguish the effects of ATP on 
Cav2.3 channels from those on other VGCCs because neither direct nucleotide binding nor 
PIP2 synthesis is required for protection from run-down. We conclude that protein 
phosphorylation is required for Cav2.3 channel function and could directly influence the 
normal features of current carried by these channels. Curiously, some of our findings also 
point to a role for leupeptin-sensitive proteases in run-up and possibly ATP protection from 
run-down. As such, the present study provides a reliable baseline for further studies on 
Cav2.3 channel regulation by protein kinases, phosphatases, and possibly proteases. 
 
Contributions to Publication 3: 
I independently conceptualized and performed all experiments, analyzed and interpreted 
the data, prepared all of the figures, wrote the manuscript and handled the submission and 
revision process.  
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2.4. Publication 4: Biochimica et Biophysica Acta 1853(5): 953-964. 
 
Diethyldithiocarbamate-mediated zinc ion chelation reveals role of Cav2.3 
channels in glucagon secretion. 
Irina Drobinskaya*, Felix Neumaier*, Alexey Pereverzev, Jürgen Hescheler, Toni 
Schneider 
* equal contribution 
 
Abstract: 
Peptide-hormone secretion is partially triggered by Ca2+ influx through voltage-gated Ca2+ 
channels (VGCCs) and gene inactivation of Zn2+-sensitive Cav2.3-type VGCCs is associated 
with disturbed glucose homeostasis in mice. Zn2+ has been implicated in pancreatic islet cell 
crosstalk and recent findings indicate that sudden cessation of Zn2+ supply during 
hypoglycemia triggers glucagon secretion in rodents. Here we show that 
diethyldithiocarbamate (DEDTC), a chelating agent for Zn2+ and other group IIB metal ions, 
differentially affects blood glucose and serum peptide hormone level in wild-type mice and 
mice lacking the Cav2.3-subunit. Fasting glucose and glucagon level were significantly higher 
in Cav2.3-deficient compared to wild-type mice, while DEDTC Zn2+-chelation produced a 
significant and correlated increase of blood glucose and serum glucagon concentration in 
wild-type but not Cav2.3-deficient mice. Glucose tolerance tests revealed severe glucose 
intolerance in Zn2+-depleted Cav2.3-deficient but not vehicle-treated Cav2.3-deficient or Zn2+-
depleted wildtype mice. Collectively, these findings indicate that Cav2.3 channels are 
critically involved in the Zn2+-mediated suppression of glucagon secretion during 
hyperglycemia. Especially under conditions of Zn2+ deficiency, ablation or dysfunction of 
Cav2.3 channels may lead to severe disturbances in glucose homeostasis. 
 
Contributions to Publication 4: 
I conceptualized and performed the whole-cell patch-clamp recordings, analyzed and 
interpreted the data from all experiments, prepared all tables and figures, wrote the 
manuscript and handled the submission and revision process. 
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2.5. Publication 5: Journal of Neurochemistry 147(3): 310-322. 
 
Reciprocal modulation of Cav2.3 voltage-gated calcium channels by copper(II) 
ions and kainic acid. 
Felix Neumaier, Isha Akhtar-Schäfer, Jan Niklas Lüke, Maxine Dibué-Adjei, Jürgen 
Hescheler, Toni Schneider 
Abstract: 
Kainic acid (KA) is a potent agonist at non-N-methyl-D-aspartate (non-NMDA) ionotropic 
glutamate receptors and commonly used to induce seizures and excitotoxicity in animal 
models of human temporal lobe epilepsy. Among other factors, Cav2.3 voltage-gated calcium 
channels have been implicated in the pathogenesis of KA-induced seizures. At 
physiologically relevant concentrations, endogenous trace metal ions (Cu2+, Zn2+) occupy an 
allosteric binding site on the domain I gating module of these channels and interfere with 
voltage-dependent gating. Using whole-cell patch clamp recordings in human embryonic 
kidney (HEK-293) cells stably transfected with human Cav2.3d and β3-subunits, we identified 
a novel, glutamate receptor-independent mechanism by which KA can potently sensitize 
these channels. Our findings demonstrate that KA releases these channels from the tonic 
inhibition exerted by low nanomolar concentrations of Cu2+ and produces a hyperpolarizing 
shift in channel voltage-dependence by about 10 mV, thereby reconciling the effects of Cu2+ 
chelation with tricine. When tricine was used as a surrogate to study the receptor 
independent action of KA in electroretinographic recordings from the isolated bovine retina, 
it selectively suppressed a late b-wave component, which we have previously shown to be 
enhanced by genetic or pharmacological ablation of Cav2.3 channels. Although the 
pathophysiological relevance remains to be firmly established, we speculate that reversal of 
Cu2+-induced allosteric suppression, presumably via formation of stable kainate-Cu2+ 
complexes, could contribute to the receptor-mediated excitatory effects of KA. In addition, 
we discuss experimental implications for the use of KA in vitro, with particular emphasis on 
the seemingly high incidence of trace metal contamination in common physiological 
solutions. 
 
Contributions to Publication 5: 
I conceptualized and performed the whole-cell patch-clamp recordings, was involved in 
interpretation of the ERG recordings, prepared all tables and figures, wrote the manuscript 
and handled the submission and revision process. 
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2.6. Publication 6: Journal of General Physiology 152(9): e202012585. 
 
Zn2+-induced changes in Cav2.3 channel function. An electrophysiological and 
modeling study. 
Felix Neumaier, Serdar Alpdogan, Jürgen Hescheler, Toni Schneider 
Abstract: 
Loosely bound Zn2+ ions are increasingly recognized as potential modulators of synaptic 
plasticity and neuronal excitability under normal and pathophysiological conditions. Cav2.3 
voltage-gated Ca2+ channels are among the most sensitive targets of Zn2+ and are therefore 
likely to be involved in the neuromodulatory actions of endogenous Zn2+. Although histidine 
residues on the external side of domain I have been implicated in the effects on Cav2.3 
channel gating, the exact mechanisms involved in channel modulation remain incompletely 
understood. Here, we use a combination of electrophysiological recordings, modification of 
histidine residues, and computational modeling to analyze Zn2+-induced changes in Cav2.3 
channel function. Our most important findings are that multiple high- and low-affinity 
mechanisms contribute to the net Zn2+ action, that Zn2+ can either inhibit or stimulate Ca2+ 
influx through Cav2.3 channels depending on resting membrane potential, and that Zn2+ 
effects may persist for some time even after cessation of the Zn2+ signal. Computer 
simulations show that (1) most salient features of Cav2.3 channel gating in the absence of 
trace metals can be reproduced by an obligatory model in which activation of two voltage 
sensors is necessary to open the pore; and (2) most, but not all, of the effects of Zn2+ can be 
accounted for by assuming that Zn2+ binding to a first site is associated with an electrostatic 
modification and mechanical slowing of one of the voltage sensors, whereas Zn2+ binding to 
a second, lower-affinity site blocks the channel and modifies the opening and closing 
transitions. While still far from complete, our model provides a first quantitative framework 
for understanding Zn2+ effects on Cav2.3 channel function and a step toward the application 
of computational approaches for predicting the complex actions of Zn2+ on neuronal 
excitability. 
 
Contributions to Publication 6: 
I independently conceptualized and performed all experiments, analyzed and interpreted 
the data, developed and optimized the Markov model, performed the simulations, prepared 
all tables and figures, wrote the manuscript and handled the submission and revision 
process. 
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3. Discussion 
The exact role of Cav2.3 channel modulation by endogenous Zn2+ and Cu2+ remains elusive, 
but our results provide evidence for a potential (patho)physiological relevance. For example, 
the findings in publication 4 indicate that Cav2.3 channels are critically involved in the Zn2+-
induced suppression of glucagon secretion and that glucose tolerance in Cav2.3-deficient 
mice is highly sensitive to Zn2+ chelation, so that dysfunction of these channels under 
conditions of Zn2+-deficiency could lead to severe disturbances in glucose homeostasis. In 
addition, in publication 5 we show that the excitatory amino acid KA can reverse 
suppression by physiological Cu2+ concentrations in vitro and stimulate Ca2+ influx through 
cloned Cav2.3 channels even in the absence of functional glutamate receptors. These and 
other findings prompted us to re-assess the effects Zn2+ as a prototype redox-inert trace metal 
ion on Cav2.3 channel function. The results described in publication 6 reveal that Zn2+-
induced Cav2.3 channel modulation is complex and inconsistent with a single mechanism of 
action, that it can be either inhibitory or stimulatory and that it may persist for several 
minutes even after cessation of the Zn2+ signal. To account for these findings, we have 
developed a preliminary Markov model that describes well many qualitative and 
quantitative features of the experimental data and could provide a starting point for future 
studies on the intricate effects of endogenous Zn2+ (and Cu2+) on Cav2.3 channel function in 
neuronal, neuroendocrine and possibly other tissues. Below, I will briefly summarize our 
findings with regard to the mechanisms of Cav2.3 channel modulation by trace metal ions 
and trace metal chelators and discuss potential implications for Cav2.3 channel function in 
the brain and endocrine pancreas.  
3.1. Mechanisms of Cav2.3 channel modulation by Zn
2+ and Cu2+ 
(Sub)micromolar concentrations of Zn2+, Cu2+ or Ni2+ produce depolarizing shifts in the 
voltage-dependence of cloned Cav2.3 channel gating, a reduced slope of the activation curve, 
a pronounced slowing of activation and a decrease in the maximum macroscopic 
conductance (Drobinskaya et al., 2015; Kang et al., 2007; Neumaier et al., 2018a; 
Shcheglovitov et al., 2012; Zamponi et al., 1996). Although histidine residues in the domain I 
VSM have been implicated in the shift and slowing (Kang et al., 2007; Shcheglovitov et al., 
2012), the underlying mechanisms, their dependence on the experimental conditions and the 
potential role of additional metal binding sites remain incompletely understood. We have 
addressed some of these questions in publication 6, the results of which indicate that 
multiple sites contribute to the effects of Zn2+. For example, concentration-response curves 
for the shift and slowing obtained under near-physiological ionic conditions revealed 
separable high- and low-affinity components, which could also be distinguished based on 
their sensitivity to histidine modification by DEPC. With 4 mM free Ca2+ as the charge 
carrier, the high-affinity effects were half-maximal at Zn2+ concentrations in the order of 4.2-
4.6 µM and produced, at most, a shift by approximately 20 mV and a two- to three-fold 
slowing of activation. These effects were reduced or prevented by histidine-modification 
with DEPC, suggesting that they result from Zn2+ binding to the putative metal binding site. 
Consistent with this assumption, computer simulations showed that both effects could be 
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well described by assuming that a single, bimolecular reaction between Zn2+ and a site on the 
channel results in electrostatic modification and mechanical slowing of one of the voltage-
sensors. Moderate acidification (from pH 7.4 to 7.0) or a decrease in the extracellular Ca2+ 
concentration (from 4 to 2 mM) significantly increased or decreased respectively, the 
apparent KZn value for high-affinity shift and slowing, indicating that there is competition for 
binding between Zn2+, Ca2+ and protons. However, while Ca2+ concentrations neither affected 
the maximum effects mediated by high-affinity binding, nor activation under control 
conditions (i.e. Ca2+ appeared to antagonize Zn2+ binding competitively), acidification 
reduced the maximum Zn2+ action and produced effects similar to Zn2+ under control 
conditions. The latter is consistent with previous findings that protons affect Cav2.3 channel 
gating by interaction with histidine residues in the proposed metal binding site (Cens et al., 
2011) and indicates that they are less effective than Zn2+, possibly because of their lower 
charge. Protons have also been shown to reduce the slope of the activation curve and to 
decrease the unitary conductance, which has been linked to a histidine residue in one of the 
pore loops of domain I (Cens et al., 2011). Our findings indicate that Zn2+ could act in a 
similar manner, since histidine-modification also prevented the Zn2+-induced slope reduction 
and a voltage-independent component of instantaneous current suppression, both of which 
became half-maximal at Zn2+ concentrations four to five times higher than the shift and 
slowing (KZn~20 µM) and were not reproduced by the model described above. Higher 
concentrations of Zn2+ also produced an additional shift and up to 5-fold slowing of 
activation and a weakly voltage-dependent block of instantaneous currents, which became 
half-maximal at Zn2+ concentrations in excess of 100 µM and were largely insensitive to 
acidification or histidine-modification. In principle, all of these effects could reflect time- and 
voltage- or state-dependent unblock, in which case re-block of channels upon repolarization 
should have accelerated macroscopic deactivation. However, depolarization actually 
increased the degree of block and high concentrations of Zn2+ produced a subtle but 
significant deceleration of channel deactivation, indicating that the slowing was not directly 
related to intrinsically voltage- or state-dependent block. Based on circumstantial evidence 
and a previously proposed mechanism, we have instead assumed that Zn2+-binding to a low 
affinity, superficial intra-pore site could block the channel and allosterically modify the 
opening and closing transitions. Computer simulations based on this idea are in reasonable 
agreement with the experimental data for free Zn2+ concentrations up to approximately 300 
µM, but other models could almost certainly account for the slowing as well. As Zn2+-
induced slowing of activation appears to be a common feature of all HVA but not LVA 
VGCCs, the underlying site may be conserved in other members of the family. For example, 
all HVA channels contain a putative EF-hand like motif that has previously been implicated 
in their differential sensitivity to Zn2+ block and is located external to the selectivity filter 
EEEE-locus (Sun et al., 2007), so that it could also account for the shallow voltage-
dependence of block. 
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3.2. Trace metal chelators as functional Cav2.3 channel agonists 
Amino acids like histidine, cysteine or L-glutamic acid (L-Glu) have long been known for 
their ability to bind trace metal ions like Zn2+ and Cu2+. More recently, L-Glu was identified 
as a potential agonist for Cav2.3 channels that acts by reversing Zn2+- or Cu2+-induced 
suppression (Shcheglovitov et al., 2012). Transient relief of tonic Cav2.3 channel inhibition by 
these metal ions following release of L-Glu into the synaptic cleft has been proposed to affect 
synaptic transmission and plasticity in the brain. In line with these observations, the results 
from publication 5 indicate that KA, a conformationally restricted analogue of L-Glu, is 
capable of reversing tonic Cu2+-induced suppression of cloned Cav2.3 channels, presumably 
by formation of stable kainate-Cu2+ complexes (Neumaier et al., 2018a). Thus, KA stimulated 
Cav2.3 channels in the presence of 50 nM nominal Cu2+ by shifting channel voltage-
dependence to more negative test potentials, increasing their voltage-sensitivity and 
accelerating the time-course of activation, consistent with a reversal of trace metal-induced 
suppression. In addition, the effects were independent of the presence of functional 
glutamate receptors but depended on pre-existing suppression by Cu2+ and could be 
reproduced by Cu2+ chelation with tricine. In brain slice recordings from the hippocampal 
area, co-administration of the related neurotoxin domoic acid with Zn2+ or Cd2+ has also been 
shown to result in the formation of trace metal-neurotoxin complexes (Hoedemaker et al., 
2005), supporting the experimental relevance of our findings in in vitro systems. In addition, 
when tricine was used as a surrogate for the receptor-independent action of KA in the 
isolated bovine retina, it produced effects consistent with increased GABAergic reciprocal 
inhibition of rod bipolar cells due to reversal of Cav2.3 channel suppression in amacrine cells 
(Neumaier et al., 2018a). Brain tissue concentrations of KA reached after systemic 
administration have not been established (Berger et al., 1986), but are likely to be much lower 
than the millimolar concentrations of L-Glu that may be transiently reached in the synaptic 
cleft. However, KA is resistant to enzymatic degradation or reuptake, binds Cu2+ much more 
tightly (logKCuL=10.1 & logKCuL2=7.6 compared to logKCuL=8.2 & logKCuL2=6.4 for L-Glu) 
(Aydin and Yirikogullari, 2010; Burns et al., 2007; Shuaib et al., 1999) and effectively reversed 
Cu2+-induced suppression at concentrations 10-times lower than L-Glu (Neumaier et al., 
2018a). As such, the pathophysiological relevance of our observations in in vivo animal 
models of KA-induced seizures remains to be established, but they support and extent 
previous findings that endogenous or exogenous trace metal-binding compounds could 
profoundly alter excitability by indirectly modifying the function of Cav2.3 and numerous 
other metal-sensitive targets (Boldyrev, 2001; Coddou et al., 2002; Eimerl and Schramm, 1993; 
Nelson et al., 2007; Shcheglovitov et al., 2012; Thio and Zhang, 2006; Trombley et al., 1998; 
Wakita et al., 2014).  
3.3. Cav2.3 channel modulation by endogenous brain Zn
2+ and Cu2+ 
The conditions under which vesicular Zn2+ and Cu2+ are released during synaptic activity and 
their exact functional significance remain enigmatic, making it difficult to predict the 
implications of Zn2+- or Cu2+-induced Cav2.3 channel modulation for neuronal transmission. 
However, a remarkable consequence of the parallel changes in activation and inactivation 
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voltage-dependence described in publication 6 is that, depending on the resting membrane 
potential (RMP) of a cell, Zn2+ could both, inhibit or stimulate Ca2+ influx via Cav2.3 channels. 
For example, currents were inhibited by application of 5.4 μM free Zn2+ when they were 
evoked from a holding potential of -80 mV, but potentiated by the same free Zn2+ 
concentration when they were evoked from a holding potential of -60 mV. Washout of Zn2+ 
resulted in a further transient current stimulation that was followed by a progressive decline 
back to the control level, presumably due to time-dependent entry into one or more 
inactivated states. Hence, even though rises in the synaptic free or loosely-bound Zn2+ 
concentration during neuronal activity are likely to be transient, they could endow Cav2.3 
channels with a form of ‘short-term memory’ that alters their properties even after cessation 
of the Zn2+ signal. This could provide a mechanism to transiently increase their availability 
following release of Zn2+ into the synaptic cleft, with potential implications for certain forms 
of synaptic sensitization or plasticity. The holding potential-dependence of Zn2+ effects could 
also be involved in the pro-ictogenic role of Cav2.3 channels observed in previous studies 
(Dibué-Adjei et al., 2017; Weiergräber et al., 2007, 2006a), since depolarization of the neuronal 
RMP due to e.g. spreading depolarization or paroxysmal depolarizing shifts could lead to a 
decrease in the inhibitory action or even reverse the direction of Zn2+ effects from inhibition 
to stimulation. In addition, our findings in publications 4-6 show that mild acidosis, as 
typically observed during seizures, or trace metal chelation by endogenous (i.e. L-Glu, 
carnosine, glutathione) or exogenous (i.e. KA, DEDTC) agents could significantly reduce the 
effects of Zn2+ or Cu2+ on Cav2.3 channel gating regardless of the holding potential. Since even 
very small changes in ion channel function (Thomas et al., 2009) and synaptic gain (Du et al., 
2019) can lead to seizure-like activity, it seems conceivable that reduced Cav2.3 channel 
suppression by Zn2+ could contribute to the ictogenic processes when the brain moves into a 
pro-seizure state. However, further studies on Zn2+-induced Cav2.3 channel modulation will 
clearly be required to firmly establish the kinetics, magnitude and direction of Zn2+ effects on 
native Cav2.3 channels in different cells, as they could be influenced by a number of factors 
such as subunit-composition or alternative splicing. For example, Cavβ-subunits have been 
shown to differentially modify the time-course of Cav2.3 channel recovery from inactivation 
at depolarized test potentials (Jeziorski et al., 2000), which could in turn alter the dynamics of 
Zn2+-induced modulation. Likewise, co-expression of different Cavβ-subunits has been 
shown differentially affect the gating effects of Ni2+ on cloned Cav2.1 channels (Zamponi et 
al., 1996), suggesting that auxiliary subunits could also directly influence trace metal-induced 
VGCC modulation.  
3.4. Cav2.3 channels as a target for paracrine Zn
2+ signals in the pancreas 
The two most important findings of our study on the role of Cav2.3 channels for blood 
glucose homeostasis are that (i) fasting glucose and glucagon levels are significantly higher 
in Cav2.3-deficient compared to wildtype mice, while (ii) the correlated increase of blood 
glucose and serum glucagon levels observed during Zn2+-chelation in wildtype mice is 
severely blunted in Cav2.3-deficient mice (Drobinskaya et al., 2015). Thus, Cav2.3-deficiency  
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Figure 5. Schema of putative Zn2+-mediated functional coupling between insulin and glucagon release. (A) 
In the presence of normal or high blood glucose concentrations, ATP level in β-cells increases, leading to 
closure of KATP channels, depolarization and co-secretion of insulin and Zn2+. In downstream α-cells, Zn2+ 
counteracts glucagon release by activation of KATP channels and inhibition of Cav2.3 channels. (B) Under 
conditions of hypoglycemia, ATP level in β-cells decreases, leading to disinhibition of KATP channels, K+ 
efflux and thus hyperpolarization with closure of voltage-gated Ca2+ channels. The resulting switch off of 
Zn2+ release from upstream β-cells is associated with closure of KATP channels and disinhibition of Cav2.3 
channels in α-cells, which ultimately leads to release of glucagon. Reprinted with permission from 
(Drobinskaya et al., 2015).  
appears to impair the coupling between blood glucose levels and glucagon secretion rather 
than reducing glucagon release per se, which could explain previous findings that glucose 
challenge produces a paradoxical stimulation of glucagon release in Cav2.3-deficient mice 
(Jing et al., 2005). According to the Zn2+ switch-off hypothesis, Zn2+ co-secreted with insulin 
during hyperglycemia could hyperpolarize α-cells by opening KATP channels, leading to 
closure of Na+ and Ca2+ channels and suppression of glucagon release (Fig. 5A) 
(Gyulkhandanyan et al., 2008; Slucca et al., 2010; Zhou et al., 2007). Sudden cessation of Zn2+ 
release during hypoglycemia could conversely depolarize α-cells through closure of KATP 
channels, leading to Na+ and L-type Ca2+ channel-dependent action potential firing and 
(during the peak of the AP) local Ca2+ influx through P/Q-type channels, which then 
mediates glucagon secretion (Fig. 5B). Considering their intermediate threshold for 
activation, Cav2.3 channel dis-inhibition upon cessation of Zn2+ supply could conceivably 
serve to amplify the effects of KATP channel closure, providing sufficient depolarization for 
subsequent Na+ and L-type Ca2+ channel-dependent AP firing. However, the fact that Cav2.3-
deficiency did not reduce overall glucagon release indicates that Cav2.3 channel opening per 
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se may not be a critical requirement for α-cell secretion, but could instead alter P/Q-type 
channel-dependent exocytosis by e.g. modifying the threshold or peak height of the APs. 
This would be consistent with their proposed role for fine-tuning of rhythmogenesis in 
oscillatory networks (Schneider et al., 2015) and with the fact that Cav2.3 channel inactivation 
at typical α-cell membrane potentials would be predicted to limit their contribution to Ca2+ 
influx and thus secretion. On the other hand, the Zn2+-induced changes in inactivation 
voltage-dependence described in publication 6 could significantly increase their availability 
at rest. Upon cessation of Zn2+-supply, rapid reversal of Zn2+-induced suppression could 
allow for a brief burst of Ca2+ influx before time-dependent inactivation would again limit 
the number of channels available for activation. Given the synchronous nature of basal 
insulin and glucagon secretion, it is tempting to speculate that (cessation of) Zn2+ release 
from pancreatic β-cells could provide some kind of impulse generator for pulsatile α-cell 
glucagon secretion, possibly triggered by Cav2.3 channels, which synchronizes the release of 
both peptide hormones. However, it has also been proposed that the suppression of 
glucagon secretion during hyperglycemia is independent of Zn2+ and results from α-cell 
glucose metabolism and closure of KATP channels, which depolarizes the cell sufficiently to 
inactivate Na+ and L-type Ca2+ channels (Göpel et al., 2004, 2000; Gromada et al., 2004). In 
this view, electrical activity and global Ca2+ oscillations remain preserved during 
hyperglycemia, but the lower AP peak height associated with Na+ and L-type Ca2+ channel 
inactivation reduces P/Q-type Ca2+ channel mediated exocytosis. Here a Zn2+-induced 
depolarizing shift in the voltage-dependence of α-cell Cav2.3 channels could allow them to 
remain active during hyperglycemia, where they might be involved in maintaining electrical 
activity and global Ca2+ oscillations. Further studies will therefore be required to define both, 
the direction of Zn2+ effects on α-cell Cav2.3 channels during hyperglycemia, and their exact 
role for regulating glucagon secretion. 
Another interesting observation of our study was that isolated islets from Cav2.3-deficient 
mice exhibit increased basal insulin secretion and reduced insulin content but normal GSIS, 
while the peripheral insulin response in vivo was significantly reduced by about 50% in 
Cav2.3-deficient mice (Drobinskaya et al., 2015). A similar 50% decrease of second phase 
insulin secretion was previously observed during in situ perfusion of pancreata from Cav2.3-
deficient mice (Jing et al., 2005), suggesting that it is not related to increased postprandial 
insulin clearance. Instead, Cav2.3 channels could also be involved in Zn2+-induced autocrine 
feedback inhibition of basal insulin secretion, so that their ablation results in excessive 
insulin release and depleted insulin stores, akin to β-cell exhaustion in rodent models of type 
2 diabetes mellitus (T2DM) (Grill et al., 1987; Kergoat et al., 1987). In non-diabetic rats, 
transient upregulation of insulin release with tolbutamide to lower β-cell insulin contents has 
been shown to selectively reduce the second phase insulin response by about 50% 
(Hosokawa and Leahy, 1997).  Basal in vivo insulin secretion is only moderately increased in 
Cav2.3-deficient compared to wildtype mice (Jing et al., 2005; Matsuda et al., 2001; 
Pereverzev et al., 2005), suggesting that neurally mediated feedback loops or other islet-
extrinsic factors could partly counter-balance intrinsic hyperinsulinemia to keep insulin 
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levels below the detrimental range. Interestingly however, we also observed that Cav2.3-
deficient mice exhibit signs of pre-diabetes followed by a progressive loss of glycemic 
control, which is consistent with previous reports that these animals may develop symptoms 
of T2DM, such as insulin resistance, glucose intolerance and overweight (Matsuda et al., 
2001). As such, they could be a valuable model for certain aspects of human T2DM, an idea 
that is reinforced by several studies linking variants in the gene encoding Cav2.3 channels to 
impaired glucose homeostasis in human T2DM patients (Holmkvist et al., 2007; Muller et al., 
2007; Trombetta et al., 2012). In particular, in Pima Indians, where a variant of the human 
Cav2.3 gene has been linked young-onset T2DM (Muller et al., 2007), high fasting plasma 
insulin concentrations predicted T2DM independent of insulin resistance, pointing to a 
causative role of basal hyperinsulinemia (Weyer et al., 2000). Based on our findings, Zn2+ 
supplementation could possibly preserve glucose tolerance in these patients and provide a 
general interventional approach for certain patient populations with T2DM. 
3.5. Conclusion 
Endogenous trace metal ions are increasingly recognized as potential modulators of 
neuronal transmission and neuroendocrine function and have been implicated in a number 
of pathophysiological conditions. Our findings confirm and extent previous findings about 
the high sensitivity of Cav2.3 channels to physiologically relevant concentrations of Zn2+ or 
Cu2+ and indicate that multiple metal binding sites are likely to be involved in the action of 
trace metal ions on these channels. In addition, they provide evidence for a potential 
pathophysiological relevance of Zn2+-induced Cav2.3 channel modulation in the context of 
T2DM and possibly epilepsy. Finally, we have developed a preliminary model that 
reproduces most salient features of Cav2.3 channel currents in the absence of trace metals and 
can also account for the hallmarks of Zn2+-induced Cav2.3 channel modulation. While still far 
from complete, our model provides a quantitative framework for understanding Zn2+ effects 
on Cav2.3 channel function and a first step towards the application of computational 
approaches for predicting the complex effects of Zn2+ on neuronal excitability.    
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